U.S. markets open in 6 hours 25 minutes
  • S&P Futures

    3,739.75
    -17.00 (-0.45%)
     
  • Dow Futures

    29,879.00
    -103.00 (-0.34%)
     
  • Nasdaq Futures

    11,480.00
    -61.75 (-0.54%)
     
  • Russell 2000 Futures

    1,751.70
    -6.40 (-0.36%)
     
  • Crude Oil

    88.23
    -0.22 (-0.25%)
     
  • Gold

    1,717.20
    -3.60 (-0.21%)
     
  • Silver

    20.70
    +0.04 (+0.19%)
     
  • EUR/USD

    0.9790
    -0.0006 (-0.06%)
     
  • 10-Yr Bond

    3.8260
    0.0000 (0.00%)
     
  • Vix

    30.52
    +1.97 (+6.90%)
     
  • GBP/USD

    1.1144
    -0.0024 (-0.22%)
     
  • USD/JPY

    145.0050
    -0.0630 (-0.04%)
     
  • BTC-USD

    19,871.58
    -321.72 (-1.59%)
     
  • CMC Crypto 200

    452.81
    -10.31 (-2.23%)
     
  • FTSE 100

    6,997.27
    0.00 (0.00%)
     
  • Nikkei 225

    27,116.11
    -195.19 (-0.71%)
     

Investigational 2.0mg Semaglutide Dose Promoted for Type 2 Diabetics With Higher A1c Score

·3 min read

Ozempics Continuing to Stand Out as a New Type 2 Diabetes Medication Alternative

Canadian pharmacy logo

Canadian pharmacy logo
Canadian pharmacy logo

VICTORIA, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Novo Nordisk introduced Ozempic to the market in 2017, giving Type 2 diabetics a different option when it comes to their injections made for keeping their blood sugar levels down and managing their diabetes effectively. Semaglutide appeals to Type 2 diabetics on several different levels, primarily for being a once-a-week injection and one that is more effective for having A1c test scores down to the standard 7% or lower. Canadian Pharmacy can fill Ozempic prescriptions for U.S. residents approved by their doctor to switch to Ozempic.

The medication is also touted as a better fit for Type 2 diabetics needing to improve scores but also be more cautious regarding cardiovascular health concerns. Those who are more at risk of a cardiac event may have their doctors recommending they move to Ozempic, and to a lesser extent, Ozempic is being discussed as a blood sugar control medication that promotes more weight loss. Users need to make diet changes and increase physical activity for Ozempic to be beneficial for them in that way.

Earlier this year, a 2.0mg dosage of Semaglutide was approved by the U.S. FDA. Novo Nordisk chose to conduct a new phase 3 clinical trial for this medication based on their findings that 70% to 80% of test participants succeeded in getting their A1c scores to 7% or lower with either the 0.5 or 1mg Ozempic dosages. The 2.0mg Semaglutide injection was suggested for the remaining 20% to 30% of users to have the same success with managing their blood sugar levels.

Trial results look promising with the higher dose getting scores down to the 7% threshold for participants unable to do so with the 0.5mg or 1mg injections. Ozempic is a GLP-1 receptor agonist medication that works to inhibit gastric emptying, and this is what makes Semaglutide different from the active ingredients in other diabetes management medications. Patients who are doing well with Ozempic but are still seeing higher A1c test scores may want to talk to their doctor about moving to the 2mg dose.

Americans may want to order Ozempic from Canada if they struggle to afford their Type 2 diabetes medication. If you are approved to switch to Ozempic, then you can evaluate your options for finding the best price on Ozempic 2.0mg.

About the Company 

Canada Pharmacy is a Canadian online pharmacy among those recommended for Americans who shop at a pharmacy in Canada to save money. It can source medications in a way that allows for the best prices on prescription drugs from Canada. All orders require a prescription and are dispensed by a licensed pharmacist, in the same way it would be with any pharmacy in America. Pay less when you order drugs online from Canada.

Contact Canada Pharmacy:

https://www.canadadpharmacy.com/

Toll-Free: 1-800-891-0844

Related Images






Image 1: Canadian pharmacy logo


Canadian pharmacy



This content was issued through the press release distribution service at Newswire.com.

Attachment